packageGusperimus

gusperimus

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Gusperimus is an investigational immunosuppressive drug that was studied for treating Wegener's granulomatosis. It is not an approved medicine; a marketing application in the European Union was withdrawn, so it remains investigational.

Summary written by glm-5.3-flash from Wikidata Q10910504 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:gusperimus
ATC codes:L04AA19
DrugBank:DB12692
PubChem CID:55362
ChEBI:135609
Wikidata:Q10910504
formula:C17H37N7O3
molar mass:387.529 g/mol (PubChem CID 55362)
logP:-2 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown